Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Corticosteroids worked better than anthralin cream for hair regrowth.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Some eczema treatments may cause conjunctivitis, many people have sensitive eyes, air pollution can increase skin wrinkles, hair loss medication does not affect sexual function, and dermatologists can help identify torture signs on refugees' skin.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Dupilumab for skin problems might reactivate hair loss in some patients.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Betamethasone injections are more effective than Clobetasol for treating alopecia areata in children.

This method is effective for needle-free HIV-1 vaccination by activating immune responses in the skin.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

New research is helping develop better treatments for alopecia areata.

Antihistamines may help with hair regrowth in alopecia areata, but dupilumab's effects are mixed.

Cryotherapy with precise temperature control is a promising treatment for alopecia areata.

New treatments like JAK inhibitors offer hope for hair regrowth in severe alopecia areata.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Mogamulizumab can cause hair loss and skin rashes.